ArticleMolecular cancer therapeutics2017

Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.

Noël J-M Raynal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.